Home › NDC Lookup › Ingredients › Tolnaftate, Undecylenic Acid › 83766-0108-01
ERWCNMIE Toenail Fungus Treatment Pen Tolnaftate, UNDECYLENIC ACID 1 g/100mL; 25 g/100mL Liquid — NDC 83766-0108-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

ERWCNMIE Toenail Fungus Treatment Pen Tolnaftate, UNDECYLENIC ACID 1 g/100mL; 25 g/100mL Liquid — NDC 83766-108-01 (Billing 83766-0108-01)

by Shenzhen Joyuflsh Technology Co.,Ltd. · 3 BOTTLE, WITH APPLICATOR in 1 PACKAGE / 5 mL in 1 BOTTLE, WITH APPLICATOR

This is a package of ERWCNMIE Toenail Fungus Treatment Pen Tolnaftate, UNDECYLENIC ACID 1 g/100mL; 25 g/100mL Liquid from Shenzhen Joyuflsh Technology Co.,Ltd., marketed since Sep 2025 and currently FDA-listed. It is the main listing for this product, which comes in 3 package sizes.

NDC 83766-0108-01
🏷️ FDA NDC (as labeled) 83766-108-01 billing pads the product segment with a zero
This package
Contains5 mL in 1 bottle, with applicator Pack sizes3 compare ↓
Main listing for product 83766-108 · Also comes in: 6 bottles 83766-108-02 9 bottles 83766-108-03
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 83766-108-01
Product NDC 83766-108
11-digit billing NDC 83766010801
RxCUI 2691548
UNII 06KB629TKV, K3D86KJ24N
Application # 505G(a)(3)
SPL Set ID 3dce0c33-d4f3-5135-e063-6394a90a85a6
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-09-02
Route TOPICAL
Dosage form LIQUID
Substance TOLNAFTATE; UNDECYLENIC ACID
Quick answers
  • RxCUI (RxNorm): 2691548
Why two NDCs? The FDA registers this code as 83766-108-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 83766-0108-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antifungals for topical use class.

Drug family (ATC) Other antifungals for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

This is a topical liquid product marketed as a toenail fungus treatment under FDA's over-the-counter monograph rules. It contains tolnaftate and undecylenic acid, both ingredients typically used in antifungal products applied to skin and nails. Tolnaftate is commonly included in topical antifungals for various fungal infections, while undecylenic acid functions as an antifungal agent often found in foot and nail care products. The liquid form allows application directly to affected nails.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 6 bottles 9 bottles
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
83766-0108-01 You're viewing this Main listing 3 BOTTLE, WITH APPLICATOR in 1 PACKAGE / 5 mL in 1 BOTTLE, WITH APPLICATOR 2025-09-02 — Active
83766-0108-02 83766-108-02 6 BOTTLE, WITH APPLICATOR in 1 PACKAGE / 5 mL in 1 BOTTLE, WITH APPLICATOR 2025-09-02 — Active
83766-0108-03 83766-108-03 9 BOTTLE, WITH APPLICATOR in 1 PACKAGE / 5 mL in 1 BOTTLE, WITH APPLICATOR 2025-09-02 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 3 bottle, with applicator in 1 package / 5 ml in 1 bottle, with applicator.
What NDC number is used to bill for this package of ERWCNMIE Toenail Fungus Treatment Pen Tolnaftate, UNDECYLENIC ACID 1 g/100mL; 25 g/100mL Liquid?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Bldaxn Fungus Nail Pen .01 g/mL; .25 g/mL 76986-0026-01 Guangdong 4 bottles — — FDA listed —
RDVHDLW Extra Strength NAIL REPAIR PEN .25 g/mL; .01 g/mL 83766-0001-01 Shenzhen 5 bottles — — FDA listed —
DRAWZONE Toenail Fungus Treatment Pen 25 g/100mL; 1 g/100mL 83766-0107-01 Shenzhen 6 bottles — — FDA listed —
ERWCNMIE Toenail Fungus Treatment Pen 1 g/100mL; 25 g/100mLthis 83766-0108-01 Shenzhen 3 bottles — — FDA listed —
Nailtific Daytime Treatment Antifungal Pen Refill 1.5 g/6mL; .06 g/6mL 84167-0012-27 Guangzhou 1 bottle — — FDA listed —
APUREE Pro Nailtific Maximum Strength Dual-Action Antifungal Pen 25 g/1; 1 g 84167-0364-02 Guangzhou 2 bottles — — FDA listed —
APUREE Nailtific Extra-Max Strength Daytime Antigungal 1 g/1; 25 g 84167-0423-01 Guangzhou 1 vial — — FDA listed —
APUREE Nailtific Extra-Max Strength Antigungal .25 g/1; .01 g 84167-0662-23 Guangzhou 5 bottles — — FDA listed —
Toenail Fungus Treatment Extra Strength Pen 1 g/100mL; 25 g/100mL 85038-0001-01 Lianjiang 3 bottles — — FDA listed —
TOENAIL FUNGUS TREATMENT Liquid 25 g/100mL; 1 g/100mL 85038-0002-01 Lianjiang 1 bottle — — FDA listed —
Yamangu Fungal Nail Repair Pen 25 g/100mL; 1 g/100mL 85248-0196-01 Jiangxi 6 tubes — — FDA listed —
Htrcsw Fungal Nail Renewal 25 g/100mL; 1 g/100mL 85248-0217-01 Jiangxi 3 tubes — — FDA listed —
cmojsk TOENAIL FUNGUS PEN 1 g/100mL; 25 g/100mL 85248-0220-01 Jiangxi 4 tubes — — FDA listed —
Fitcube NAIL REPAIR PEN 25 g/100mL; 1 g/100mL 85248-0230-01 Jiangxi 4 tubes — — FDA listed —
TAGOQHIA Extra Strength NAIL REPAIR PEN 25 g/100mL; 1 g/100mL 85304-0031-01 Guangzhou 3 bottles — — FDA listed —
Extra Strength Nail Fungus Treatment 1 g/100mL; 25 g/100mL 85966-0001-01 GUANGZHOU 30 ml — — FDA listed —
Nail Fungus Treatment Pen 25 g/100mL; 1 g/100mL 85966-0005-01 GUANGZHOU 3 bottles — — FDA listed —
Extra Strength Toenaiil Renewal Pen .01 g/mL; .25 g/mL 85966-0010-01 GUANGZHOU 5 ml — — FDA listed —
EXTRA STRENGTH TOENAIIL RENEWAL Solution .25 g/mL; .01 g/mL 85966-0011-01 GUANGZHOU 1 bottle — — FDA listed —
Extra Strength Toenail Renewal Pen .25 g/mL; .01 g/mL 85966-0012-01 GUANGZHOU 5 ml — — FDA listed —
Extra Strength Toenail Renewal Solution .25 g/mL; .01 g/mL 85966-0013-01 GUANGZHOU 30 ml — — FDA listed —
SSPROTIP X Extra Strength Toenail Renewal Solution .01 g/mL; .25 g/mL 85966-0017-01 GUANGZHOU 1 bottle — — FDA listed —
ONIADBA Fungal Nail Treatment Swabs 1 g/100mL; 25 g/100mL 85992-0002-01 Shenzhen 23 ml — — FDA listed —
WCTNGO Fungal Nail Treatment Swabs 1 g/100mL; 25 g/100mL 85992-0003-01 Shenzhen 23 ml — — FDA listed —
ONIADBA Nail Fungus Treatment Pen 1 g/100mL; 25 g/100mL 85992-0004-01 Shenzhen 4 tubes — — FDA listed —
Putrizen 1 g/4g; .04 g/4g 87724-5118-01 Guangzhou 5 applicators — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Sep 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerShenzhen Joyuflsh Technology Co.,Ltd.
FDA application505G(a)(3) (OTC MONOGRAPH DRUG)
Labeler code83766
First marketedSep 2025
Product typeHuman Otc Drug
Portfolio6 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 13 words ▾

For the effective treatment of nail fungus-including discoloration,. thickening, splitting, crumbling, and brittleness.

⏱️ Dosage and Administration 57 words ▾

1.Wash and dry your nails thoroughly before applying the product.Remove the cap that covers the brush. 2.Twist the end of the pen clockwise to dispense the liquid onto thebrush. 3.Apply the liquid three times to the areas requiring treatment,ensuring complete coverage of all affected parts. 4.Use 2 times daily for 2-4 weeks, depending on the condition beingtreated.

⚠️ Warnings 4 words ▾

For external use only.

🧪 Active Ingredient 5 words ▾

Tolnaftate 1% UNDECYLENIC ACID 25%

🧪 Inactive Ingredients 18 words ▾

ALCOHOL POLYETHYLENE GLYCOL PROPYLENE GLYCOL DIMETHICONE C12-15 ALKYL LACTATE ETHYLHEXYLGLYCERIN GLYCERIN LAUROCAPRAM SOPHORA FLAVESCENS ROOT TOCOPHEROL PHENOXYETHANOL WATER

🎯 Purpose 4 words ▾

Anti-fungal and Nail Renewal

📄 Do Not Use 17 words ▾

Children under 2 years of age. Pregnant or if there is any allergic reaction to this produce.

📄 When Using This Product 11 words ▾

Avoid contact with eyes. lf in eyes, rinse thoroughly with water.

📄 Stop Use and Ask a Doctor If 5 words ▾

lrritation occurs or discomfort persists.

📄 Keep Out of Reach of Children 13 words ▾

If accidental ingestion occurs, seek medical attention immediatelyand contact a Poison Control Center.

📄 Package Label / Principal Display Panel 1 words ▾

label

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Shenzhen Joyuflsh Technology Co.,Ltd.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 2 other package presentations of this same product, including 6 bottles (83766-0108-02), 9 bottles (83766-0108-03). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Shenzhen Joyuflsh Technology Co.,Ltd. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 83766-0107-01 · Shenzhen 83772-1001-01 · Vanamali →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.